SCHEMBL6067895

SCHEMBL6067895

COC(=O)N1CCCC(NC(c2ccccc2)(c2ccccc2)c2ccccc2)C1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 2/20 0.47
▸ KMT2A Q03164 1/20 0.41
▸ EPHX2 P34913 1/20 0.41
▸ GAA P10253 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ PER2 O15055 1/20 0.39
▸ CRY1 Q16526 1/20 0.39
▸ CRY2 Q49AN0 1/20 0.39
▸ NPY2R P49146 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3460745 0.83 ALDH1A1 (0.40) EPHX2GAAALDH1A1TSHR
SCHEMBL10282277 0.73 SMN1; SMN2 (0.52) USP30KMT2ACYP2C19
SCHEMBL12207836 0.73 CA1 (0.43) USP30ALDH1A1TSHR
SCHEMBL15644903 0.71 USP30 (0.62) USP30ALDH1A1
SCHEMBL20970042 0.71 USP30 (0.62) USP30ALDH1A1
SCHEMBL15644901 0.71 USP30 (0.62) USP30ALDH1A1
SCHEMBL20986645 0.71 USP30 (0.56) USP30BRD4
SCHEMBL20986647 0.71 USP30 (0.56) USP30BRD4
SCHEMBL11731985 0.71 TSHR (0.47) USP30KMT2AALDH1A1LMNATSHR
SCHEMBL19493611 0.71 RAB9A (0.62) KMT2AALDH1A1LMNAHPGDHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7101891-B2 Compounds and pharmaceutical compositions for inhibiting MRP1 ELI LILLY AND COMPANY (US) 2006-09-05 — — US disclosed
US-20040116460-A1 Compounds and pharmaceutical compositions for inhibiting mrp1 COHEN JEFFREY DANIEL (US) 2004-06-17 — — US disclosed
EP-1392701-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING MRP1 ELI LILLY AND COMPANY (US) 2004-03-03 — — EP disclosed
WO-2002081480-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING MRP1 ELI LILLY AND COMPANY (US) 2002-10-17 — — WO disclosed
Send feedback